THE INVITRO AND INVIVO ACTIVITY OF CIPROFLOXACIN

被引：159

作者：

ZEILER, HJ ^{[1
]}

GROHE, K ^{[1
]}

机构：

[1] BAYER AG,RES & DEV,D-5090 LEVERKUSEN,FED REP GER

来源：

EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES | 1984年 / 3卷 / 04期

关键词：

D O I：

10.1007/BF01977490

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

引用

页码：339 / 343

页数：5

共 5 条

[1] INVITRO ACTIVITY OF CIPROFLOXACIN, NORFLOXACIN AND NALIDIXIC-ACID [J].

BAUERNFEIND, A ;

PETERMULLER, C .

EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1983, 2 (02) :111-115

[2] INVITRO ANTI-BACTERIAL ACTIVITY OF AM-715, A NEW NALIDIXIC-ACID ANALOG [J].

ITO, A ;

HIRAI, K ;

INOUE, M ;

KOGA, H ;

SUZUE, S ;

IRIKURA, T ;

MITSUHASHI, S .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1980, 17 (02) :103-108

[3] PIPEMIDIC ACID, A NEW ANTIBACTERIAL AGENT ACTIVE AGAINST PSEUDOMONAS-AERUGINOSA - INVITRO PROPERTIES [J].

SHIMIZU, M ;

TAKASE, Y ;

NAKAMURA, S ;

KATAE, H ;

MINAMI, A ;

NAKATA, K ;

INOUE, S ;

ISHIYAMA, M ;

KUBO, Y .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1975, 8 (02) :132-138

[4] INVITRO ACTIVITY OF BAY-09867, A NEW QUINOLINE DERIVATIVE, COMPARED WITH THOSE OF OTHER ANTI-MICROBIAL AGENTS [J].

WISE, R ;

ANDREWS, JM ;

EDWARDS, LJ .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1983, 23 (04) :559-564

[5]

[No title captured]

← 1 →